Philips Signs Agreement to Create Taiwan's First Fully Digitalized Pathology Department

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Taipei Veterans General Hospital (TPVGH) will utilize the Philips IntelliSite Pathology Solution to transform its pathology tissue examination to digital diagnostics. By allowing tissue samples to be remotely viewed within a virtual pathology network across hospital locations, the Philips IntelliSite Pathology Solution will help TPVGH to establish Taiwan's first fully digitalized pathology department, with the aim of enhancing patient safety and improving the quality of diagnoses, thereby leading to better patient outcomes.

Cancer is the leading cause of death in Taiwan. Pathology plays a critical role in the detection and diagnosis of a wide variety of diseases, including cancer. Tissue samples (biopsies) are examined to determine if tissue cells are malignant and consequently to guide treatment decisions. Speedy diagnosis and effective personalized treatment have a significant impact on patients and their families.

Pathological review of patient tissue has historically been done using a microscope. Using the Philips IntelliSite Pathology Solution with the Ultra-Fast Scanner (UFS), TPVGH will now be able to digitize tissue samples so that pathologists can review, interpret, analyze, and share digital images. The Image Management System (IMS) that is part of the Philips IntelliSite Pathology Solution allows them to instantly consult colleagues or conveniently present images during multi-disciplinary team meetings, without the need to physically transport pathology slides or tissue samples.

"Philips Taiwan continues to help Taiwan in realizing intelligent and advanced healthcare solutions," said Richard Hu, General Manager of Philips Taiwan. "Digitalizing pathology so that tissue samples can be viewed remotely, wherever they are needed, will not only enhance laboratory efficiency and quality but also improve patient safety."

In addition to clinical use, the digital images will be stored in image repositories and used to teach pathology students, or used for medical research, including cancer research.

Philips IntelliSite Pathology Solution is designed for in-vitro diagnostic purposes, helping pathologists to review and interpret digital images of surgical pathology slides prepared from formalin-fixed paraffin-embedded (FFPE) tissue samples. It has market access clearance in over fifty countries, including recent market clearance in Taiwan.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 78,000 employees with sales and services in more than 100 countries.

Most Popular Now

Apple Health Records Available for Allsc…

Allscripts (NASDAQ: MDRX) announced that Apple Health Records is now available for Allscripts Sunrise™, TouchWorks® and Professional EHR™ clients and their patients. Health Records brings together hospitals, clinics and the...

Machine Learning Improves the Diagnosis …

Researchers from Charité - Universitätsmedizin Berlin and the German Cancer Consortium (DKTK) have successfully solved a longstanding problem in the diagnosis of head and neck cancers. Working alongside colleagues from...

Robotic Thread is Designed to Slip throu…

MIT engineers have developed a magnetically steerable, thread-like robot that can actively glide through narrow, winding pathways, such as the labrynthine vasculature of the brain. In the future, this robotic...

St Helens and Knowsley Advance with Ambi…

St Helens and Knowsley Teaching Hospitals NHS Trusthas successfully gone live with System C’s CareFlow Vitals as part of its ambitious strategy to accelerate digitisation and become a digital exemplar...

The Future of Mind Control

Electrodes implanted in the brain help alleviate symptoms like the intrusive tremors associated with Parkinson's disease. But current probes face limitations due to their size and inflexibility. "The brain is...

Experimental Validation Confirms the Abi…

Insilico Medicine, a global leader in artificial intelligence for drug discovery, today announced the publication of a paper titled, "Deep learning enables rapid identification of potent DDR1 kinase inhibitors," in...

Using a Smartphone to Detect Norovirus

A little bit of norovirus - the highly infectious microbe that causes about 20 million cases of food poisoning in the United States each year - goes a long way...

Medical Informatics Europe Conference 20…

28 April - 1 May 2020, Geneva, Switzerland. The European Federation of Medical Informatics (EFMI) presents the 30th Medical Informatics Europe conference (MIE) at the Geneva International Conference Center (CICG). This...

FRONTIERS HEALTH Comes Back to the Heart…

13 - 15 November 2019, Berlin, Germany. FRONTIERS HEALTH is a global event on digital health innovation with a strong focus on digital therapies, breakthrough technologies, healthcare transformation, investments and ecosystem...

International HL7 Interoperability Confe…

22 - 24 October 2019, Warsaw, Poland. 19th International HL7® Interoperability Conference (IHIC) will be held in Warsaw, Poland. The event, organized by HL7 Poland, will focus on implementation of healthcare...